CAS: 1352914-52-3
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | CR-1-31-B REF: 4Z-K-031114CAS: 1352914-52-3 | - - - | To inquire | Tue 18 Mar 25 |
 | Cr-1-31-B REF: 3D-CEC91452CAS: 1352914-52-3 | Min. 95% | To inquire | Tue 22 Apr 25 |
 | CR-1-31-B REF: TM-T38753CAS: 1352914-52-3 | - - - | 663.00 €~2,242.00 € | Tue 13 May 25 |
Ref: 4Z-K-031114
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 18 Mar 2025
Cr-1-31-B
CAS:1352914-52-3
Cr-1-31-B is a peptide inhibitor of the protein interactions. It has been shown to be …
Formula:
C28H29NO8
Purity:
Min. 95%
Molecular weight:
507.5 g/mol
Ref: 3D-CEC91452
| 1mg | 559.00 € | ||
| 2mg | 905.00 € | ||
| 5mg | 1,628.00 € | ||
| 10mg | 2,629.00 € | ||
| 500µg | 408.00 € |
Estimated delivery in United States, on Tuesday 22 Apr 2025
CR-1-31-B
CAS:1352914-52-3
CR-1-31-B, a synthetic rocaglate, inhibits eIF4A, hinders protein synthesis initiation, and induces apoptosis in cancer …
Formula:
C28H29NO8
Color and Shape:
Solid
Molecular weight:
507.539
Ref: TM-T38753
| 5mg | 663.00 € | ||
| 10mg | 1,130.00 € | ||
| 25mg | 2,242.00 € |
Estimated delivery in United States, on Tuesday 13 May 2025
